MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance

Mednax Reports Fourth Quarter Results

February 17, 2022 6:00 AM EST

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Mednax, Inc. (NYSE: MD), and its affiliated practices operating as Pediatrix® Medical Group, the nations leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.47 per share for the three months ended December 31, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.52.

For the 2021 fourth quarter, Mednax reported the following results from continuing operations:

Net revenue of $499 million; Income from continuing operations of $68 million;... More